Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Harvard Bioscience Gross Margin 2010-2025 | HBIO

Current and historical gross margin for Harvard Bioscience (HBIO) over the last 10 years. The current gross profit margin for Harvard Bioscience as of March 31, 2025 is %.
  
Harvard Bioscience Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.09B $0.05B 56.52%
2024-12-31 $0.10B $0.06B 57.89%
2024-09-30 $0.10B $0.06B 58.16%
2024-06-30 $0.10B $0.06B 58.42%
2024-03-31 $0.11B $0.06B 58.88%
2023-12-31 $0.11B $0.07B 58.93%
2023-09-30 $0.11B $0.07B 58.93%
2023-06-30 $0.11B $0.06B 55.26%
2023-03-31 $0.11B $0.06B 55.26%
2022-12-31 $0.11B $0.06B 53.98%
2022-09-30 $0.12B $0.07B 55.08%
2022-06-30 $0.12B $0.07B 57.02%
2022-03-31 $0.12B $0.07B 56.20%
2021-12-31 $0.12B $0.07B 56.30%
2021-09-30 $0.12B $0.07B 55.56%
2021-06-30 $0.11B $0.06B 55.86%
2021-03-31 $0.11B $0.06B 57.14%
2020-12-31 $0.10B $0.06B 56.86%
2020-09-30 $0.10B $0.06B 55.88%
2020-06-30 $0.11B $0.06B 56.19%
2020-03-31 $0.11B $0.06B 54.46%
2019-12-31 $0.12B $0.06B 55.17%
2019-09-30 $0.12B $0.07B 55.46%
2019-06-30 $0.12B $0.07B 55.37%
2019-03-31 $0.12B $0.07B 53.66%
2018-12-31 $0.12B $0.06B 51.64%
2018-09-30 $0.11B $0.06B 50.00%
2018-06-30 $0.10B $0.05B 49.00%
2018-03-31 $0.09B $0.04B 49.43%
2017-12-31 $0.08B $0.04B 51.28%
2017-09-30 $0.08B $0.04B 50.00%
2017-06-30 $0.09B $0.04B 48.86%
2017-03-31 $0.10B $0.05B 48.42%
2016-12-31 $0.10B $0.05B 47.12%
2016-09-30 $0.11B $0.05B 47.17%
2016-06-30 $0.11B $0.05B 46.73%
2016-03-31 $0.11B $0.05B 46.36%
2015-12-31 $0.11B $0.05B 44.95%
2015-09-30 $0.11B $0.05B 45.05%
2015-06-30 $0.11B $0.05B 44.55%
2015-03-31 $0.11B $0.05B 44.44%
2014-12-31 $0.11B $0.05B 45.37%
2014-09-30 $0.11B $0.05B 44.34%
2014-06-30 $0.11B $0.05B 44.34%
2014-03-31 $0.11B $0.05B 44.76%
2013-12-31 $0.11B $0.05B 44.76%
2013-09-30 $0.11B $0.05B 45.71%
2013-06-30 $0.11B $0.05B 46.23%
2013-03-31 $0.11B $0.05B 47.22%
2012-12-31 $0.11B $0.05B 47.27%
2012-09-30 $0.11B $0.05B 46.85%
2012-06-30 $0.11B $0.05B 46.85%
2012-03-31 $0.11B $0.05B 46.36%
2011-12-31 $0.11B $0.05B 46.30%
2011-09-30 $0.11B $0.05B 46.79%
2011-06-30 $0.11B $0.05B 47.71%
2011-03-31 $0.11B $0.05B 47.22%
2010-12-31 $0.11B $0.05B 48.15%
2010-09-30 $0.11B $0.05B 48.11%
2010-06-30 $0.10B $0.05B 47.52%
2010-03-31 $0.09B $0.05B 48.39%
2009-12-31 $0.09B $0.04B 47.67%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.018B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.295B 17.68
Kewaunee Scientific (KEQU) United States $0.172B 10.85